Detroit Vape Shop FDA Investigations – Defense Lawyer

What To Do If FDA or the U.S. Attorney Contacts You

The Situation—Why Detroit Shops Are Getting Scrutiny

Since 2024, the FDA Center for Tobacco Products (CTP) has ramped up enforcement against unauthorized flavored and disposable e-cigarettes, issuing waves of warning letters, civil money penalty (CMP) complaints, and coordinating with DOJ for seizures and injunctions. DOJ announced a nationwide sweep in September 2025 seizing 2+ million illicit vaping products and filing civil injunctions to stop future violations—part of a whole-of-government push that includes FDA, DOJ, CBP, and sometimes ATF and U.S. Marshals.

Key backdrop:

• Most flavored disposables remain unauthorized unless they’ve received PMTA marketing authorization (very few have). Products without authorization are at risk for enforcement.

• FDA has repeatedly targeted retailers (including brick-and-mortar) for selling brands like Elf Bar/Lost Mary and similar youth-appealing products.

• FDA also ended the carve-outs around synthetic nicotine—meaning NTN products are fully under FDA tobacco authority.

While national press releases don’t list every local action, Detroit-area retailers fall within the Eastern District of Michigan—the U.S. Attorney’s Office that partners with FDA/DOJ on seizures, injunctions, and (in some cases) criminal referrals. If you’ve received a warning letter, inspection notice, administrative subpoena, CMP complaint, seizure notice, or a call from an agent, you’re in the enforcement stream.

What Triggers Enforcement?

• Selling unauthorized ENDS (no granted PMTA/MGO).

• Flavored disposables and youth-appealing designs (phones/game devices, cartoon branding).

• Repeat noncompliance after a prior warning letter. (Escalation to CMPs/injunctions is common.)

• Import/wholesale chains routing products through local retailers; CBP seizures upstream can prompt local follow-ups.

What Agencies Can Do

• FDA Warning Letters / CMPs (civil money penalties) for selling unauthorized products.

• DOJ Civil Injunctions & Product Seizures under the FDCA (21 U.S.C. §§ 332, 334).

• Coordinated sweeps (FDA/DOJ/CBP/DEA/ATF/Marshals) removing stock and freezing operations temporarily.

If You’ve Been Contacted—First 72 Hours

1. Do not ignore the letter or call. Deadlines are tight; silence escalates cases. (CMPs and injunctions often follow a warning.)

2. Stop selling the named products immediately (at least pending counsel review). This can mitigate penalties.

3. Preserve documents: invoices, supplier emails, shipping/CBP docs, PMTA/MDO status sheets, brand authorization representations.

4. Inventory freeze & segregation: identify all allegedly unauthorized SKUs and batch/lot data.

5. Call counsel before you respond, consent to an interview, or sign anything.

Defense & Resolution Strategies I Use

• Rapid Risk Audit: Map SKUs against FDA authorization lists; confirm brand claims; flag synthetic-nicotine exposure.

• Regulatory Posture Letter: A calibrated response that addresses each allegation, shows immediate corrective actions, and frames good-faith compliance. (Goal: avoid CMPs/injunctions.)

• Negotiating Scope & Remedies: Limit any injunction to specific SKUs, timelines, and reporting duties; avoid overbroad language that would hamstring lawful sales. Department of Justice

• Upstream Pressure: Pursue indemnity/repurchase from distributors who misrepresented authorization status.

• Parallel-Proceeding Management: If CBP or state agencies are involved, align the narrative and production across forums to reduce contradictions.

• Compliance Program Build-Out: SKU-intake checklist, supplier warranties, authorization verification, POS controls, age-gate protocols, and document retention—so you’re not back in the crosshairs next quarter. U.S. Food and Drug Administration

Potential Consequences (and How We Try to Avoid Them)

• Product seizure / destruction and inventory loss. Department of Justice

• Civil money penalties and injunctions that can shut down key revenue SKUs. U.S. Food and Drug Administration

• Public press releases that hurt reputation and vendor relationships. (Yes, USAOs post these.) Department of Justice

• Criminal exposure is rare for first-time retailers but possible with fraud, smuggling, or repeat defiance. (We structure early moves to avoid this track.) Department of Justice

How I Can Help

• Same-day assessment of your letter, subpoena, or inspection report.

• Communicate with FDA/DOJ on your behalf—professionally, promptly, and without admissions that box you in.

• Negotiate remedies that minimize penalties and keep the doors open.

• Design a practical compliance plan tailored to Detroit retail realities (supplier vetting, SKU gating, documentation).

FAQs

Are any flavored vapes legal?
Only products with granted marketing orders are lawful to sell. Very few flavored ENDS are authorized; most flavored disposables are unauthorized. Congress.gov

I got an FDA warning letter—am I done if I pull the product?
Pulling helps, but FDA often checks for repeat compliance; ignoring or delaying a response can trigger CMPs or injunctions. U.S. Food and Drug Administration

What about synthetic nicotine (NTN)?
It’s regulated as a tobacco product since 2022; NTN disposables without authorization are enforcement targets. Michigan.gov

Why is DOJ involved, not just FDA?
FDA partners with DOJ for seizures and injunctions—and to increase deterrence. The Sept. 2025 sweep shows the model.